Literature DB >> 22969023

The biomarker revolution.

Enrique F Schisterman1, Paul S Albert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22969023      PMCID： PMC4121863          DOI： 10.1002/sim.5499

Source DB:  PubMed          Journal:  Stat Med        ISSN： 0277-6715            Impact factor:   2.373


× No keyword cloud information.
  11 in total

1.  Using pooled exposure assessment to improve efficiency in case-control studies.

Authors:  C R Weinberg; D M Umbach
Journal:  Biometrics       Date:  1999-09       Impact factor: 2.571

2.  ROC curve analysis for biomarkers based on pooled assessments.

Authors:  David Faraggi; Benjamin Reiser; Enrique F Schisterman
Journal:  Stat Med       Date:  2003-08-15       Impact factor: 2.373

3.  Logistic regression analysis of biomarker data subject to pooling and dichotomization.

Authors:  Z Zhang; A Liu; R H Lyles; B Mukherjee
Journal:  Stat Med       Date:  2011-09-23       Impact factor: 2.373

4.  Pooling biospecimens and limits of detection: effects on ROC curve analysis.

Authors:  Sunni L Mumford; Enrique F Schisterman; Albert Vexler; Aiyi Liu
Journal:  Biostatistics       Date:  2006-03-10       Impact factor: 5.899

5.  Estimation of ROC curves based on stably distributed biomarkers subject to measurement error and pooling mixtures.

Authors:  Albert Vexler; Enrique F Schisterman; Aiyi Liu
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

6.  Pooling designs for outcomes under a Gaussian random effects model.

Authors:  Yaakov Malinovsky; Paul S Albert; Enrique F Schisterman
Journal:  Biometrics       Date:  2011-10-09       Impact factor: 2.571

7.  Assessment of skewed exposure in case-control studies with pooling.

Authors:  Brian W Whitcomb; Neil J Perkins; Zhiwei Zhang; Aijun Ye; Robert H Lyles
Journal:  Stat Med       Date:  2012-03-22       Impact factor: 2.373

8.  Likelihood-based methods for regression analysis with binary exposure status assessed by pooling.

Authors:  Robert H Lyles; Li Tang; Ji Lin; Zhiwei Zhang; Bhramar Mukherjee
Journal:  Stat Med       Date:  2012-03-13       Impact factor: 2.373

9.  Hybrid pooled-unpooled design for cost-efficient measurement of biomarkers.

Authors:  Enrique F Schisterman; Albert Vexler; Sunni L Mumford; Neil J Perkins
Journal:  Stat Med       Date:  2010-02-28       Impact factor: 2.373

10.  Estimation of gene-environment interaction by pooling biospecimens.

Authors:  M R Danaher; E F Schisterman; A Roy; P S Albert
Journal:  Stat Med       Date:  2012-08-01       Impact factor: 2.373
View more
  6 in total

Review 1.  Promise, Progress, and Pitfalls in the Search for Central Nervous System Biomarkers in Neuroimmunological Diseases: A Role for Cerebrospinal Fluid Immunophenotyping.

Authors:  Bibiana Bielekova; Michael R Pranzatelli
Journal:  Semin Pediatr Neurol       Date:  2017-08-12       Impact factor: 1.636

Review 2.  Diagnostic Accuracy of Liquid Biomarkers in Airway Diseases: Toward Point-of-Care Applications.

Authors:  Vivianne Landry; Patrick Coburn; Karen Kost; Xinyu Liu; Nicole Y K Li-Jessen
Journal:  Front Med (Lausanne)       Date:  2022-06-06

3.  An Empirical Validation of the Within-subject Biospecimens Pooling Approach to Minimize Exposure Misclassification in Biomarker-based Studies.

Authors:  Céline Vernet; Claire Philippat; Lydiane Agier; Antonia M Calafat; Xiaoyun Ye; Sarah Lyon-Caen; Pierre Hainaut; Valérie Siroux; Enrique F Schisterman; Rémy Slama
Journal:  Epidemiology       Date:  2019-09       Impact factor: 4.822

Review 4.  Methodological Issues in the Clinical Validation of Biomarkers for Alzheimer's Disease: The Paradigmatic Example of CSF.

Authors:  Marco Canevelli; Ilaria Bacigalupo; Giuseppe Gervasi; Eleonora Lacorte; Marco Massari; Flavia Mayer; Nicola Vanacore; Matteo Cesari
Journal:  Front Aging Neurosci       Date:  2019-10-17       Impact factor: 5.750

5.  Managing the moral expansion of medicine.

Authors:  Bjørn Hofmann
Journal:  BMC Med Ethics       Date:  2022-09-22       Impact factor: 2.834

6.  Within-subject Pooling of Biological Samples to Reduce Exposure Misclassification in Biomarker-based Studies.

Authors:  Flavie Perrier; Lise Giorgis-Allemand; Rémy Slama; Claire Philippat
Journal:  Epidemiology       Date:  2016-05       Impact factor: 4.822
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.